欧盟HMA药品数据库（European Union HMA Authorisation of Medicines DataBase）
MR编号NL/H/4453/001
药品名称Gelaspan, oplossing voor infusie
活性成分
    • succinylated gelatin 4.0 %
剂型Solution for infusion
上市许可持有人B. BRAUN MELSUNGEN AG Carl-Braun-Strasse 1 34212 Melsungen Germany
参考成员国 - 产品名称Netherlands (NL)
Gelaspan, oplossing voor infusie
互认成员国 - 产品名称
    • United Kingdom (Northern Ireland) (XI)
      PL 03551/0120 - 0023
    • Germany (DE)
      Gelaspan 4% Infusionslösung
    • Denmark (DK)
    • Luxembourg (LU)
    • Austria (AT)
      Gelofusin Iso 40 mg/ml Infusionslösung
    • France (FR)
    • Spain (ES)
    • Italy (IT)
    • Norway (NO)
    • Lithuania (LT)
      Gelaspan 4% infuzinis tirpalas
    • Estonia (EE)
      GELASPAN
    • Sweden (SE)
      Gelaspan
    • Portugal (PT)
    • Ireland (IE)
    • Belgium (BE)
    • Malta (MT)
      Gelaspan 4% solution for infusion
    • Slovenia (SI)
      Gelaspan 40 mg/ml raztopina za infundiranje
    • Slovakia (SK)
      Gelaspan 4%
    • Bulgaria (BG)
      Gelofusine Balance
    • Hungary (HU)
      GELASPAN 4% oldatos infúzió
    • Latvia (LV)
      Gelaspan 4% šķīdums infūzijām
    • Poland (PL)
    • Romania (RO)
      Gelaspan 40 mg/ml soluţie perfuzabilă
    • Czechia (CZ)
      Gelaspan 4%
许可日期2011/05/19
最近更新日期2023/11/17
药物ATC编码
    • B05AA06 gelatin agents
申请类型
  • TypeLevel1：[not specified]
  • TypeLevel2：[not specified]
  • TypeLevel3：[not specified]
  • TypeLevel4：[not specified]
  • TypeLevel5：[not specified]
附件文件下载
市场状态Positive
©2006-2024 Drugfuture->European Union HMA Authorisation of Medicines DataBase